Compare AstraZeneca plc (AZN) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Vistra Corp — how do they compare? AstraZeneca plc trades at $157.94 (market cap $248.14B), while Vistra Corp trades at $146.25 (market cap $48.64B). The key difference: AstraZeneca plc is far larger — about 5.1× Vistra Corp's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | VST | |
|---|---|---|
Market Cap | $248.14B | $48.64B |
Sector | Health | Technology |
52-Week High | $209.48 | $217.92 |
52-Week Low | $147.06 | $134.71 |
Enterprise Value | $275.41B | $70.58B |
Dividend Yield | 2.01% | 0.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
